Pritchard C - Search Results

1

DNMT3B Oncogenic Activity in Human Intestinal Cancer Is Not Linked to CIMP or BRAFV600E Mutation.

MacKenzie DJ, Robertson NA, Rather I, Reid C, Sendzikaite G, Cruickshanks H, McBryan T, Hodges A, Pritchard C, Blyth K, Adams PD. MacKenzie DJ, et al. Among authors: pritchard c. iScience. 2020 Feb 21;23(2):100838. doi: 10.1016/j.isci.2020.100838. Epub 2020 Jan 14. iScience. 2020. PMID: 32058953 Free PMC article.

2

V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4a.

Carragher LA, Snell KR, Giblett SM, Aldridge VS, Patel B, Cook SJ, Winton DJ, Marais R, Pritchard CA. Carragher LA, et al. EMBO Mol Med. 2010 Nov;2(11):458-71. doi: 10.1002/emmm.201000099. EMBO Mol Med. 2010. PMID: 20941790 Free PMC article.

3

Cyp24a1 Attenuation Limits Progression of Braf^V600E -Induced Papillary Thyroid Cancer Cells and Sensitizes Them to BRAF^V600E Inhibitor PLX4720.

Zou M, Baitei EY, BinEssa HA, Al-Mohanna FA, Parhar RS, St-Arnaud R, Kimura S, Pritchard C, Alzahrani AS, Assiri AM, Meyer BF, Shi Y. Zou M, et al. Among authors: pritchard c. Cancer Res. 2017 Apr 15;77(8):2161-2172. doi: 10.1158/0008-5472.CAN-16-2066. Epub 2017 Feb 27. Cancer Res. 2017. PMID: 28242615 Free PMC article.

4

Expression of endogenous oncogenic V600EB-raf induces proliferation and developmental defects in mice and transformation of primary fibroblasts.

Mercer K, Giblett S, Green S, Lloyd D, DaRocha Dias S, Plumb M, Marais R, Pritchard C. Mercer K, et al. Among authors: pritchard c. Cancer Res. 2005 Dec 15;65(24):11493-500. doi: 10.1158/0008-5472.CAN-05-2211. Cancer Res. 2005. PMID: 16357158 Free PMC article.

5

Cdx2 initiates histodifferentiation of the midgut endoderm.

Stringer EJ, Pritchard CA, Beck F. Stringer EJ, et al. FEBS Lett. 2008 Jul 23;582(17):2555-60. doi: 10.1016/j.febslet.2008.06.024. Epub 2008 Jun 23. FEBS Lett. 2008. PMID: 18577384 Free article.

6

MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients.

Lenos K, Goos JA, Vuist IM, den Uil SH, Delis-van Diemen PM, Belt EJ, Stockmann HB, Bril H, de Wit M, Carvalho B, Giblett S, Pritchard CA, Meijer GA, van Kooyk Y, Fijneman RJ, van Vliet SJ. Lenos K, et al. Among authors: pritchard ca. Oncotarget. 2015 Sep 22;6(28):26278-90. doi: 10.18632/oncotarget.4495. Oncotarget. 2015. PMID: 26172302 Free PMC article.

7

Matter of TIME: the tumor-immune microenvironment of mesothelioma and implications for checkpoint blockade efficacy.

Harber J, Kamata T, Pritchard C, Fennell D. Harber J, et al. Among authors: pritchard c. J Immunother Cancer. 2021 Sep;9(9):e003032. doi: 10.1136/jitc-2021-003032. J Immunother Cancer. 2021. PMID: 34518291 Free PMC article. Review.

8

The cholesterol-binding protein NPC2 restrains recruitment of stromal macrophage-lineage cells to early-stage lung tumours.

Kamata T, Jin H, Giblett S, Patel B, Patel F, Foster C, Pritchard C. Kamata T, et al. Among authors: pritchard c. EMBO Mol Med. 2015 Sep;7(9):1119-37. doi: 10.15252/emmm.201404838. EMBO Mol Med. 2015. PMID: 26183450 Free PMC article.

9

Mouse models for BRAF-induced cancers.

Pritchard C, Carragher L, Aldridge V, Giblett S, Jin H, Foster C, Andreadi C, Kamata T. Pritchard C, et al. Biochem Soc Trans. 2007 Nov;35(Pt 5):1329-33. doi: 10.1042/BST0351329. Biochem Soc Trans. 2007. PMID: 17956344 Free PMC article. Review.

10

Expression of kinase suppressor of Ras in the normal adult and embryonic mouse.

Giblett SM, Lloyd DJ, Light Y, Marais R, Pritchard CA. Giblett SM, et al. Cell Growth Differ. 2002 Jul;13(7):307-13. Cell Growth Differ. 2002. PMID: 12133899

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

670 results

Search Page

Filters